International Artal, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 23.51M shares in CAVA Group, Inc. (Ticker: CAVA), holds 175.10M shares in Lexicon Pharmaceuticals (Ticker: LXRX), holds 2.40M shares in Scholar Rock Holding (Ticker: SRRK). Most recently, International Artal Sold ― shares of CAVA Group, Inc. on Jun 07, 2024 for an estimated value of 261.75M.